HOWL
Werewolf Therapeutics, Inc. · Healthcare
Director Luke Evnin sold $52K of Werewolf Therapeutics, Inc.
Sold$51,951
$1.08Price
48,171Shares
−2%Stake
What HOWL did after the filing
- The stock from Thu, Dec 18 open, $0.80
- −17.3%
- S&P 500, same days
- +2.6%
Measured over 30 trading days, to the Feb 3 close.
Traded Mon, Dec 15. Filed Wed, Dec 17, 6:28 PM ET, after the close. Returns use the Dec 18 open and the Feb 3 close. Not investment advice.